Participation to the ASEV and CzeSEV 2024 meeting
We participated to the ASEV and CzeSEV 2024 meeting in Vienna, Austria September 26th, 2024, Vienna, Austria We participated to the
Review on fetal-maternal interactions by LifeSaver Project Consortium
New review published by LifeSaver Project Consortium September 5th, 2024, Vienna, Austria The LifeSaver Project Consortium has published a comprehensive review
Partnering with Chameleon Science
Partnering with Chameleon Science August 19th, 2024, Vienna, Austria We are thrilled to announce that we have partnered with the new
Newly released telomerized amniotic epithelial cells
Newly released telomerized amniotic epithelial cells August 13th, 2024, Vienna, Austria We are thrilled to announce the newest addition to our
Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024
Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024 June 27th, 2024, Vienna, Austria We participated as technology spotlight speakers at
hTERT immortalized ASC for large-scale EV production
Recent publication showcasing our ASC/TERT1 cells as EV production system May 23rd, 2024, Vienna, AustriaOur telomerized human adipose derived MSC (ASC/TERT1, also known in
Evercyte proudly introduces the EVscale™ platform
Evercyte proudly introduces the EVscale™ platform April 29th, 2024, Vienna, Austria The collaborative effort of Evercyte, Phoenestra, and TAmiRNA has yielded the EVscale™ platform,
Newly published study featuring our PODO/TERT256 cell line
Recent publication showcasing our PODO/TERT256 telomerized cell line February 16th, 2024, Vienna, Austria Our telomerized human podocyte cells (PODO/TERT256) were employed in an
Evercyte contributing to reduce animal testing at key events
Evercyte contributing to reduce animal testing at key events December 7th, 2023, Vienna, Austria We participated as an invited attendee at
Evercyte Showcases Expertise in Japan’s Pharma Landscape
Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our